Swiss Startup Framework: A Highly Effective Network Supporting the Generation of Emerging Biotech Businesses
Keywords:Biotechnology, Financing, Innovation, Startup, Therapeutics
AbstractFor over 50 years, Switzerland has been one of the leading countries driving innovation in biotechnology and its industrial applications. Today, some 1,000 biotech companies form a tightly knit, cross-functional network ranging from research through to manufacturing. This network comprises R&D companies, contract research organizations, and highly specialized advisors and biotech investors. Together, they form an external innovation pool that complements the in-house R&D capacity of the large multi-national pharma companies. A highly effective startup framework, solid acceleration mechanisms, and innovative investors enable the emergence of a continuous flow of biotech startups that revitalize the industry with new technologies and products supporting drug development and diagnostics.
How to Cite
I. Mitchell, S. Steiner, M. Altorfer, L. Suter-Dick, Chimia 2020, 74, 765, DOI: 10.2533/chimia.2020.765.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.